Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | TERT | O14746 | 3/20 | 0.68 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.68 |
| ▸ | PPARG | P37231 | 3/20 | 0.68 |
| ▸ | PPARD | Q03181 | 3/20 | 0.68 |
| ▸ | PPARA | Q07869 | 3/20 | 0.68 |
| ▸ | FAAH | O00519 | 3/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.68 |
| ▸ | BLM | P54132 | 2/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.68 |
| ▸ | FABP4 | P15090 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | GMNN | O75496 | 1/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15500041 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL1114784 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL3228812 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL3123425 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL22230778 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL5478764 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL7243894 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL6713314 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL22230779 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG | |
| SCHEMBL11060705 | 1.00 | ALDH1A1 (0.75) | ALDH1A1TSHRTERTPTPN1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118239859-A | Hydrazide compound, rubber composition, and preparation methods and applications thereof | 中策橡胶集团股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-118239859-A | Hydrazide compound, rubber composition, and preparation methods and applications thereof | 中策橡胶集团股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-118064204-A | Cooling liquid for cutting silicon wafer and preparation method thereof | 江苏美科太阳能科技股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| EP-1691814-B9 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE ENTPR LTD (GB) | 2013-02-20 | — | — | EP | disclosed |
| EP-1691814-B1 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE ENTPR LTD (GB) | 2012-07-25 | — | — | EP | disclosed |
| EP-2279741-A2 | Caprolactams and their use as anti-inflammatory agents | Cambridge Enterprise Ltd. (GB) | 2011-02-02 | — | — | EP | disclosed |
| US-7511163-B2 | Creatine-fatty acids | MULTI FORMULATIONS LTD (CA) | 2009-03-31 | — | — | US | disclosed |
| US-20080227724-A1 | 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2008-09-18 | — | — | US | disclosed |
| WO-2008101310-A1 | CREATINE-FATTY ACIDS | MULTI FORMULATIONS LTD. (CA) | 2008-08-28 | — | — | WO | disclosed |
| WO-2008101313-A1 | PREPARATION OF AMINO ACID-FATTY ACID AMIDES | MULTI FORMULATIONS LTD. (CA) | 2008-08-28 | — | — | WO | disclosed |
| US-20080200704-A1 | PREPARATION OF AMINO ACID-FATTY ACID AMIDES | MULTI FORMULATIONS LTD. (CA) | 2008-08-21 | — | — | US | disclosed |
| US-20080200705-A1 | CREATINE-FATTY ACIDS | MULTI FORMULATIONS LTD. (CA) | 2008-08-21 | — | — | US | disclosed |
| US-7319157-B1 | Creatine-fatty acids | MULTI FORMULATIONS LTD. (CA) | 2008-01-15 | — | — | US | disclosed |
| EP-1691814-A2 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2006-08-23 | — | — | EP | disclosed |
| WO-2005053702-A2 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2005-06-16 | — | — | WO | disclosed |
| US-6548486-B1 | New viricide compounds of the general formula: Nu-O-Fa, wherein O represents an oxygen, Nu is a nucleoside or nucleoside analogue, and Fa is an acyl group of mono-unsaturated c18-c20 fatty acid | NORSK HYDRO A.S. (NO) | 2003-04-15 | — | — | US | disclosed |
| EP-0642525-A1 | CHEMICAL COMPOUNDS. | NORSK HYDRO AS (NO) | 1995-03-15 | — | — | EP | disclosed |
| WO-1993007163-A1 | CHEMICAL COMPOUNDS | NORSK HYDRO A.S. (NO) | 1993-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200704-A1 | PREPARATION OF AMINO ACID-FATTY ACID AMIDES | FABP2, FABP4, FABP1 | ALDH1A1 1384/4885TSHR 1140/4885TERT 3240/4885 |
| US-20080200705-A1 | CREATINE-FATTY ACIDS | CPT1B, FABP2, FABP1 | ALDH1A1 910/4885TSHR 1225/4885TERT 1064/4885 |
| US-20080227724-A1 | 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents | SMURF1, SMURF2, PSEN1 | ALDH1A1 1775/4885TSHR 2532/4885TERT 1954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.